Analysis of blood transfusion predictors in patients undergoing elective oesophagectomy for cancer

BMC Surgery

Volumn 8, Issue , 2008, Pages

  Ayantunde, Abraham A ^a   Ng, Ming Y ^a   Pal, Saurov ^a   Welch, Neil T ^a   Parsons, Simon L ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; HEMOGLOBIN;

ADULT; AGED; ANEMIA; ARTICLE; BLEEDING; BLOOD TRANSFUSION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PREDICTOR VARIABLE; RISK FACTOR; BLOOD GROUP TYPING; COHORT ANALYSIS; COST CONTROL; ECONOMICS; ELECTIVE SURGERY; ESOPHAGUS TUMOR; MEDICAL AUDIT; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERIOPERATIVE PERIOD; RETROSPECTIVE STUDY; STATISTICAL MODEL; UNITED KINGDOM; UTILIZATION REVIEW;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GROUPING AND CROSSMATCHING; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; COHORT STUDIES; COST CONTROL; ENGLAND; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MEDICAL AUDIT; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERIOPERATIVE CARE; RETROSPECTIVE STUDIES; RISK FACTORS; SURGICAL PROCEDURES, ELECTIVE;

EID: 40849094616     PISSN: None     EISSN: 14712482     Source Type: Journal    
DOI: 10.1186/1471-2482-8-3     Document Type: Article

References (25)

1. Classification of adenocarcinoma of the oesophagastric junction. JR Siewert HJ Stein, Br J Surg 1998 85 1457 1459 10.1046/j.1365-2168.1998.00940.x 9823902
2. Adenocarcinoma of the oedophagogastric junction: Results of surgical therapy based onanatomic/topographic classification in 1002 consecutive patients. JR Siewert M Feith M Werner HJ Stein, Ann Surg 2000 232 3 253 361 10.1097/00000658-200009000-00007
3. Cancer statistics 2000. T Robert T Murray S Bolden, CA Cancer J Clin 2000 50 7 33 10735013
4. Current role of erythropoietin in the management of patients with haematological and solid malignancies. M Mano P Butzberger A Reid A Rodger R Soutar J Welsh, Cancer Therapy 2005 3 41 56
5. Measures of body iron stores and iron deficiency anaemia in patients with oesophagogastric cancers. AA Ayantunde NT Welch SL Parsons, Hepato-Pancreato-Biliary (HPB) Journal 2006 8 Supplement 192
6. Biological basis of anaemia. D Bron N Meuleman C Mascaux, Semin Oncol 2001 28 Suppl 8 1 6 10.1016/S0093-7754(01)90205-2
7. The role of cytokines in cancer related fatigue. R Kurzrock, Cancer 2001 92 1684 1688 10.1002/1097-0142(20010915)92:6+<1684::AID-CNCR1497>3.0.CO;2- Z 11598887
8. Learning curve for oesophageal cancer surgery. DN Sutton J Wayman SM Griffin, Br J Surg 1998 85 1399 1402 10.1046/j.1365-2168.1998.00962.x 9782024
9. Perioperative anaemia: an independent risk factor for infection, mortality, and resource utilization in surgery. JR Dunne D Malone JK Tracy C Gannon LM Napolitano, The Journal of surgical research 2002 102 2 237 244 10.1006/jsre.2001.6330 11796024
10. Transfusion medicine. Part I: blood transfusion. LT Goodnough ME Brecher MH Kanter JP AuBuchon, N Engl J Med 1999 340 438 447 10.1056/NEJM199902113400606 9971869
11. Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. LM Williamson S Lowe EM Love, BMJ 1999 319 16 19 10390452
12. Prognostic significance of peri-operative blood transfusion following radical resection for oesophageal carcinoma. SM Dresner PJ Lamb J Shenfine N Hayes SM Griffin, EJSO 2000 26 492 497 10.1053/ejso.1999.0929 11016472
13. th January 2007
14. The maximum surgical blood order schedule and surgical blood use in the United States. BA Friedman HA Oberman AR Chadwick KI Kingon, Transfusion 1976 380 387 951737
15. A reduction in type and screen: preoperative prediction of RBC transfusions in surgery procedures with intermediate transfusion risks. WA vanKlei KGM Moons AT Rheineck-Leyssius CJ Kalkman JTA Knape, Br J Anaesth 2001 87 250 257 10.1093/bja/87.2.250 11493498
16. Validation of a clinical prediction rule to reduce preoperative type and screen procedures. WA vanKlei KGM Moons AT Rheineck-Leyssius CJ Kalkman CLG Rutten, Br J Anaesth 2002 89 221 225 10.1093/bja/aef139 12378656
17. Reducing unnecessary cross matching: A patient-specific blood ordering system is more accurate in predicting who will receive a blood transfusion than the maximum blood ordering system. T Palmer JA Wahr MO Reilly MLVH Greenfield, Anaesth Analg 2003 96 369 375 10.1097/00000539-200302000-00013
18. Long-term survival after blood transfusion. EG Vamvakas HF Taswell, Trasnfusion 1994 34 471 477 10.1046/j.1537-2995.1994.34694295060.x
19. The annual cost of blood transfusions in the UK. SJ Varney JF Guest, Transfusion Medicine 2003 13 205 218 10.1046/j.1365-3148.2003.00443.x 12880391
20. Where does blood go? Prospective observational study of red cells transfusion in north England. AW Wells PJ Mounter CE Chapman D Stainsby JP Wallis, BMJ 2002 325 803 12376439 10.1136/bmj.325.7368.803
21. Guidelines for the use of red cell transfusions. The British Committee for Standards in Haematology(BCSH), Br J Haematol 2001 113 24 31 10.1046/j.1365-2141.2001.02701.x 11328275
22. The blood stocks management scheme, a partnership venture between the National Blood Service of England and North Wales and participating hospitals for maximizing blood supply chain management. JF Chapman R Cook, Vox Sanguinis 2002 83 239 246 10.1046/j.1423-0410.2002.00218.x 12366766
23. The impact of a 10-year audit cycle on blood usage in a district general hospital. RM James S Brown LA Parapia AT Williams, Transfusion Medicine 2001 11 371 375 10.1046/j.1365-3148.2001.00324.x 11696230
24. Preoperative prediction of intra- and postoperative red cell transfusion in surgical patients. AH Ong KM Sim SK Boey, Ann Acad Med Singapore 1997 26 430 434 9395804
25. Predictors of transfusion risk in elective knee surgery. EM Keating JB Meding PM Faris MA Ritter, Clin Orthop 1998 50 90 9917700